For citations:
Egshatyan L.V. Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor. Osteoporosis and Bone Diseases. 2017;20(3):102-107.
Egshatyan L.V. Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor. Osteoporosis and Bone Diseases. 2017;20(3):102-107.